4-(Methoxymethyl)-2-phenyl-6-(pyrrolidin-1-yl)pyrimidine

Catalog No. :
ACBKEE425
CAS No. :
339278-93-2
Molecular Formula :
C16H19N3O
Molecular Weight :
269.35

IUPAC Name:4-(methoxymethyl)-2-phenyl-6-(pyrrolidin-1-yl)pyrimidine

4-(Methoxymethyl)-2-phenyl-6-(pyrrolidin-1-yl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Methoxymethyl)-2-phenyl-6-(pyrrolidin-1-yl)pyrimidine
IUPAC Name4-(methoxymethyl)-2-phenyl-6-(pyrrolidin-1-yl)pyrimidine
MDL No.MFCD00794773
Molecular FormulaC16H19N3O
Molecular Weight269.35
SMILESCOCC1=NC(C2=CC=CC=C2)=NC(N3CCCC3)=C1
InChI KeyWNVAVECPPMEFNA-UHFFFAOYSA-N
SynonymMETHYL [2-PHENYL-6-(1-PYRROLIDINYL)-4-PYRIMIDINYL]METHYL ETHER;4-(METHOXYMETHYL)-2-PHENYL-6-(1-PYRROLIDINYL)PYRIMIDINE;4-(methoxymethyl)-2-phenyl-6-(pyrrolidin-1-yl)pyrimidine;Pyrimidine, 4-(methoxymethyl)-2-phenyl-6-(1-pyrrolidinyl)-
CAS No.339278-93-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBKEE425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACBKEE425 route product structure diagram
    ACBKEE425339278-93-2
Inquiry

2. ACBKEE425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFYHM173 route compound structure diagram
    ACFYHM173325685-59-4 In Stock
  4. Then
  5. ACBKEE425 route product structure diagram
    ACBKEE425339278-93-2
Inquiry

Comments (0)